Pensions & Investments Logo
ETF Exchange > XPH ETF

XPH - ETF Fact Sheet

State Street SPDR S&P Pharmaceuticals ETF - USD

Fund Identification

Ticker

XPH

ISIN

US78464A7220

Main Metrics

Price

$61.77

Expense Ratio

0.35%

AuM

$441.70M

Tracking Difference

-0.36%

Ratings

Trackinsight rating

★★★★★

Official Investment Strategy

The SPDR® S&P® Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Pharmaceuticals Select Industry® Index The S&P Pharmaceuticals Select Industry® Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets IndexTM. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ® National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.

XPH's historical prices, performance, and flows

-8.0-6.0-4.0-2.00.02.04.0%
1m returns
-7.33%
1m flows
-$90M
* Net total returns
All data as of 16 October 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all XPH data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

XPH's characteristics

Manager statistics

389 funds, $2,350.9Bn in AUM

Benchmark

S&P Pharmaceuticals Select Industry Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
XPH's exposure

Countries

USA
96.24%

Sectors

Healthcare
99.99%

Top 5 holdings

Amylyx Pharmaceuticals, Inc.
3.65%
Crinetics Pharmaceuticals, Inc.
3.60%
MBX Biosciences, Inc.
2.89%
Omeros Corp.
2.68%
Enliven Therapeutics, Inc.
2.28%
Total holdings
62
Total weight of top 5
15.11%

ETF Education Center

4.0%